 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 September 1994 | Volume 121 Issue 6 | Pages 393-399
Objectives: To compare the effects of oral suspensions of megestrol acetate, 800 mg/d, and placebo on body weight in patients with acquired immunodeficiency syndrome (AIDS)-related weight loss.
Design: Randomized, double-blind, placebo-controlled trial.
Setting: Outpatient community and university patient care setting.
Patients: Consecutive patients with AIDS who had substantial weight loss and anorexia were enrolled. Of 271 patients, 270 and 195 were evaluable for safety and efficacy, respectively.
Interventions: Patients were randomly assigned to receive placebo or megestrol acetate (100 mg, 400 mg, or 800 mg) daily for 12 weeks.
Main Outcome Measures: The primary efficacy criterion was weight gain. Patients were evaluated at 4-week intervals for changes in weight and body composition, caloric intake, sense of well-being, toxic effects, and appetite.
Results: For evaluable patients receiving 800 mg of megestrol acetate per day, 64.2% gained 2.27 kg (5 pounds) or more compared with 21.4% of patients receiving placebo (P < 0.001). An intent-to-treat analysis showed significant differences (P = 0.002) between those receiving placebo and those receiving 800 mg of megestrol acetate for the number of patients who gained 2.27 kg (5 pounds) or more (8 of 32 [25%] compared with 38 of 61 [62.3%], respectively). Compared with patients receiving placebo at the time of maximum weight change, evaluable patients receiving megestrol acetate, 800 mg/d, reported improvement in overall well-being and had an increase in mean weight gain ( –0.725 compared with 3.54 kg [ –1.6 compared with +7.8 pounds]; P < 0.001), lean body mass ( –0.772 compared with +1.14 kg [ –1.7 compared with +2.5 pounds]; P < 0.001), appetite grade (P < 0.001), and caloric intake ( –107 compared with +645.6 calories/d; P = 0.001).
Conclusions: In patients with AIDS-related weight loss, megestrol acetate can stimulate appetite, food intake, and statistically significant weight gain that is associated with a patient-reported improvement in an overall sense of well-being.
ARTICLE
Megestrol Acetate in Patients with AIDS-related Cachexia
This article has been cited by other articles:
 |
|
 |
|
  K. Mulligan, R. Zackin, J. H. Von Roenn, M. A. Chesney, M. J. Egorin, F. R. Sattler, C. A. Benson, T. Liu, T. Umbleja, S. Shriver, et al. Testosterone Supplementation of Megestrol Therapy Does Not Enhance Lean Tissue Accrual in Men with Human Immunodeficiency Virus-Associated Weight Loss: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E Morley, D. R Thomas, and M.-M. G Wilson Cachexia: pathophysiology and clinical relevance. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 735 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Mattox Treatment of Unintentional Weight Loss in Patients With Cancer Nutr Clin Pract, August 1, 2005; 20(4): 400 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Storer, L. J. Woodhouse, F. Sattler, A. B. Singh, E. T. Schroeder, K. Beck, M. Padero, P. Mac, K. E. Yarasheski, P. Geurts, et al. A Randomized, Placebo-Controlled Trial of Nandrolone Decanoate in Human Immunodeficiency Virus-Infected Men with Mild to Moderate Weight Loss with Recombinant Human Growth Hormone as Active Reference Treatment J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4474 - 4482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mulligan, R. Zackin, R. A. Clark, B. Alston-Smith, T. Liu, F. R. Sattler, T. B. Delvers, J. S. Currier, and for the AIDS Clinical Trials Group 329 Study Team Effect of Nandrolone Decanoate Therapy on Weight and Lean Body Mass in HIV-Infected Women With Weight Loss: A Randomized, Double-blind, Placebo-Controlled, Multicenter Trial Arch Intern Med, March 14, 2005; 165(5): 578 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cuerda, A. Zugasti, I. Breton, M. Camblor, P. Miralles, and P. Garcia Treatment With Nandrolone Decanoate and Megestrol Acetate in HIV-Infected Men Nutr Clin Pract, February 1, 2005; 20(1): 93 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Lambert, M. G. Flynn, D. H. Sullivan, and W. J. Evans Effects of Megestrol Acetate on Circulating Interleukin-15 and Interleukin-18 Concentrations in Healthy Elderly Men J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): M855 - M858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dahele and K. Fearon Research methodology: cancer cachexia syndrome Palliative Medicine, July 1, 2004; 18(5): 409 - 417. [Abstract] [PDF]
|
|
|
|
|
|
C. P. Lambert, D. H. Sullivan, and W. J. Evans Megestrol Acetate-Induced Weight Gain Does Not Negatively Affect Blood Lipids in Elderly Men: Effects of Resistance Training and Testosterone Replacement J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2003; 58(7): M644 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Somerfield, A. Jatoi, P. L. Nguyen, S. Kumar, J. Sloan, and C. L. Loprinzi Hazards of Quality-of-Life Data for Clinical Decision Making J. Clin. Oncol., May 1, 2003; 21(90090): 82s - 83. [Full Text] [PDF]
|
|
|
|
|
|
C. P. Lambert, D. H. Sullivan, and W. J. Evans Effects of Testosterone Replacement and/or Resistance Training on Interleukin-6, Tumor Necrosis Factor Alpha, and Leptin in Elderly Men Ingesting Megestrol Acetate: A Randomized Controlled Trial J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2003; 58(2): M165 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gomez, P. Ruiz, R. Lopez, and C. Rivera Treatment with Megestrol Acetate Improves Human Immunodeficiency Virus-Associated Immune Thrombocytopenia Clin. Vaccine Immunol., May 1, 2002; 9(3): 583 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Somerfield, A. Jatoi, P. L. Nguyen, S. Kumar, J. Sloan, and C. L. Loprinzi Hazards of Quality-of-Life Data for Clinical Decision Making J. Clin. Oncol., January 15, 2001; 19(2): 594 - 595. [Full Text] [PDF]
|
|
|
|
|
|
S.-s. Yeh, S.-y. Wu, D. M. Levine, T. S. Parker, J. S. Olson, M. R. Stevens, and M. W. Schuster The Correlation of Cytokine Levels With Body Weight After Megestrol Acetate Treatment in Geriatric Patients J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 48M - 54. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. P. KOTLER Body Composition Studies in HIV-Infected Individuals Ann. N.Y. Acad. Sci., May 1, 2000; 904(1): 546 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bhasin, T. W. Storer, M. Javanbakht, N. Berman, K. E. Yarasheski, J. Phillips, M. Dike, I. Sinha-Hikim, R. Shen, R. D. Hays, et al. Testosterone Replacement and Resistance Exercise in HIV-Infected Men With Weight Loss and Low Testosterone Levels JAMA, February 9, 2000; 283(6): 763 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fox-Wheeler, L. Heller, C. M. Salata, F. Kaufman, M. L. Loro, V. Gilsanz, M. Haight, G. C. Umman, N. Barton, and J. A. Church Evaluation of the Effects of Oxandrolone on Malnourished HIV-Positive Pediatric Patients Pediatrics, December 1, 1999; 104(6): 73e - 73. [Abstract] [Full Text]
|
|
|
|
|
|
T. E. Finucane, C. Christmas, and K. Travis Tube Feeding in Patients With Advanced Dementia: A Review of the Evidence JAMA, October 13, 1999; 282(14): 1365 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Loprinzi, J. W. Kugler, J. A. Sloan, J. A. Mailliard, J. E. Krook, M. B. Wilwerding, K. M. Rowland Jr, J. K. Camoriano, P. J. Novotny, and B. J. Christensen Randomized Comparison of Megestrol Acetate Versus Dexamethasone Versus Fluoxymesterone for the Treatment of Cancer Anorexia/Cachexia J. Clin. Oncol., October 1, 1999; 17(10): 3299 - 3306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-S. Yeh and M. W Schuster Geriatric cachexia: the role of cytokines Am. J. Clinical Nutrition, August 1, 1999; 70(2): 183 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Corcoran and S. Grinspoon Treatments for Wasting in Patients with the Acquired Immunodeficiency Syndrome N. Engl. J. Med., June 3, 1999; 340(22): 1740 - 1750. [Full Text] [PDF]
|
|
|
|
|
|
E. S Engelson, D. P Kotler, Y. Tan, D. Agin, J. Wang, R. N Pierson Jr, and S. B Heymsfield Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1162 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Strawford, T. Barbieri, M. Van Loan, E. Parks, D. Catlin, N. Barton, R. Neese, M. Christiansen, J. King, and M. K. Hellerstein Resistance Exercise and Supraphysiologic Androgen Therapy in Eugonadal Men With HIV-Related Weight Loss: A Randomized Controlled Trial JAMA, April 14, 1999; 281(14): 1282 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Bistrian Dietary Treatment in Secondary Wasting and Cachexia J. Nutr., January 1, 1999; 129(1): 290S - 290S. [Full Text] [PDF]
|
|
|
|
|
|
S. Bhasin, T. W. Storer, N. Asbel-Sethi, A. Kilbourne, R. Hays, I. Sinha-Hikim, R. Shen, S. Arver, and G. Beall Effects of Testosterone Replacement with a Nongenital, Transdermal System, Androderm, in Human Immunodeficiency Virus-Infected Men with Low Testosterone Levels J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3155 - 3162. [Abstract] [Full Text]
|
|
|
|
|
|
K. Miller, C. Corcoran, C. Armstrong, K. Caramelli, E. Anderson, D. Cotton, N. Basgoz, L. Hirschhorn, R. Tuomala, D. Schoenfeld, et al. Transdermal Testosterone Administration in Women with Acquired Immunodeficiency Syndrome Wasting: A Pilot Study J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2717 - 2725. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Grinspoon, C. Corcoran, H. Askari, D. Schoenfeld, L. Wolf, B. Burrows, M. Walsh, D. Hayden, K. Parlman, E. Anderson, et al. Effects of Androgen Administration in Men with the AIDS Wasting Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial Ann Intern Med, July 1, 1998; 129(1): 18 - 26. [Abstract] [Full Text]
|
|
|
|
|
|
K. Mulligan, V. W. Tai, and M. Schambelan Effects of Chronic Growth Hormone Treatment on Energy Intake and Resting Energy Metabolism in Patients with Human Immunodeficiency Virus-Associated Wasting--A Clinical Research Center Study J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1542 - 1547. [Abstract] [Full Text]
|
|
|
|
|
|
P. Pertel and M. Till Intractable Hiccups Induced by the Use of Megestrol Acetate Arch Intern Med, April 13, 1998; 158(7): 809 - 810. [Full Text] [PDF]
|
|
|
|
|
|
R. H. Clarick, W. A. Hanekom, R. Yogev, and E. G. Chadwick Megestrol Acetate Treatment of Growth Failure in Children Infected With Human Immunodeficiency Virus Pediatrics, March 1, 1997; 99(3): 354 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Waters, J. Danska, K. Hardy, F. Koster, C. Qualls, D. Nickell*, S. Nightingale, N. Gesundheit, D. Watson, and D. Schade Recombinant Human Growth Hormone, Insulin-like Growth Factor 1, and Combination Therapy in AIDS-Associated Wasting: A Randomized, Double-Blind, Placebo-Controlled Trial Ann Intern Med, December 1, 1996; 125(11): 865 - 872. [Abstract] [Full Text]
|
|
|
|
|
|
M. Schambelan, K. Mulligan, C. Grunfeld, E. S. Daar, A. LaMarca, D. P. Kotler, J. Wang, S. A. Bozzette, and J. B. Breitmeyer Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting: A Randomized, Placebo-Controlled Trial Ann Intern Med, December 1, 1996; 125(11): 873 - 882. [Abstract] [Full Text]
|
|
|
|
 |
|
 The HIV Wasting Syndrome AIDS Clinical Care, November 1, 1996; 1996(1101): 1 - 1. [Full Text]
|
|
|
|
|
|
M. C. Leinung, R. Liporace, and C. H. Miller Induction of Adrenal Suppression by Megestrol Acetate in Patients with AIDS Ann Intern Med, June 1, 1995; 122(11): 843 - 845. [Abstract] [Full Text]
|
|
|
|
|
|
U. R. Hengge, N. H. Brockmeyer, and M. Goos Megestrol for AIDS-Related Anorexia Ann Intern Med, June 1, 1995; 122(11): 879 - 881. [Full Text]
|
|
|
|
|
|
P. P. Cook Megestrol for AIDS-Related Anorexia Ann Intern Med, June 1, 1995; 122(11): 879 - 881. [Full Text]
|
|
|
|
|
|
M. H. Cohen Megestrol for AIDS-Related Anorexia Ann Intern Med, June 1, 1995; 122(11): 879 - 881. [Full Text]
|
|
|
|
|
|
M. Maurer Megestrol for AIDS-Related Anorexia Ann Intern Med, June 1, 1995; 122(11): 879 - 881. [Full Text]
|
|
|
|
|
|
D. C. Hodgson and D. A. Redelmeier Megestrol for AIDS-Related Anorexia Ann Intern Med, June 1, 1995; 122(11): 879 - 881. [Full Text]
|
|
|
|
|
|
N. M. Flynn, S. R. Enders, M. H. Oster, and J. H. Von Roenn Megestrol for AIDS-Related Anorexia Ann Intern Med, June 1, 1995; 122(11): 879 - 881. [Full Text]
|
|
|
|
 |
|
 MEGESTROL FOR AIDS-RELATED CACHEXIA Journal Watch (General), September 23, 1994; 1994(923): 1 - 1. [Full Text]
|
|
|
|
|
|
D. G. Haller Weight Gain in Patients with AIDS-related Cachexia: Is Bigger Better? Ann Intern Med, September 15, 1994; 121(6): 462 - 463. [Full Text]
|
|
Article
